| DE2175871: A method of treating Rheumatic and Musculo-Skeletal Disorders (RMSDs), including rheumatoid arthritis and osteoarthritis in an anumal, herbal preparations for degenerative disorders:osteoarthritis and rheumatoid arthritis | DE2175871 |
| DE2254978: A process for enrichment of methyl ricinoleate from castor oil methyl esters by liquid-liquid extraction | DE2254978 |
| DE2257555: Thieno[2,3-D]-Pyrimidine-4(3H)-One compounds with antifungal properties and process thereof | DE2257555 |
| DE2269062: Secreted and plasma membrane associated biomarkers for the diagnosis of higher- and lower-grade astrocytoma | DE2269062 |
| DE2346861: Thiophene containing analogues of fluconazole as antifungal agents and process thereof | DE2346861 |
| DE2379175: Synthesis of hexadecyl c/s-9-tetradecenoate and hexadecyl c/s-10-tetradecenoate and their evaluation for anti arthritis properties in rats | DE2379175 |
| DE2401066: A process for deacidification using membranes | DE2401066 |
| DE2501706: Synthesis Of Novel 3-Substituted (7-Imino-2-Thioxo-3,7-Dihydro-2h-Thiazolo 4,5-D] Pyrimidin-6-Yl)-Urea And Furan-2-Carboxylic Acid (7-Imino-2-Thioxo-3,7-Dihydro-2h-Thiazolo [4,5-D] Pyrimidin-6-Yl)-Amide As Potential Adenosine A2a Receptor Antagonists | DE2501706 |
| DE2539057: ABPBI based porous membranes | DE2539057 |
| DE2545105: Surface modified porous polymers for enhanced cell growth | DE2545105 |